From: Systemic therapy response evaluation in prostate carcinoma with [68Ga]Ga-PSMA-11 PET/CT
 | [68Ga]Ga-PSMA-11 PET/CT | Total | |||||
---|---|---|---|---|---|---|---|
Progression | Stable | Partial regression | Complete regression | ||||
Serum PSA | Progression | No | 19 | 2 | 0 | 0 | 21 |
% within PSA | 90.5% | 9.5% | 0% | 0% | 100% | ||
% within PET/CT | 76% | 40% | 0% | 0% | 40% | ||
Stable | No | 2 | 3 | 3 | 0 | 8 | |
% within PSA | 25% | 37.5% | 37.5% | 0% | 100% | ||
% within PET/CT | 8% | 60% | 15% | 0% | 18% | ||
Regression | No | 4 | 0 | 17 | 0 | 21 | |
% within PSA | 19% | 0% | 81% | 0% | 100% | ||
% within PET/CT | 16% | 0% | 85% | 0% | 42% | ||
Total | No | 25 | 5 | 20 | 0 | 50 | |
% within PSA | 50% | 10% | 40% | 0% | 100% | ||
% within PET/CT | 100% | 100% | 100% | 0% | Â |